肺癌早期诊断相关标志物研究进展

肺癌是死亡率居于我国首位的肿瘤，早发现、早诊断是影响肺癌治疗效果的关键，但目前仍然缺乏精准安全的肺癌早期诊断方法，这极大地影响了肺癌患者的生存期。肺癌作为一种高度恶性肿瘤，其诊断生物标志物的相关研究受到了极大的关注。这些诊断生物标志物具有多样性，在肺癌早期诊断中的价值有待进一步探讨。

Research Progress of Markers Related to Early Diagnosis of Lung Cancer

Lung cancer is the cancer with the highest mortality in China. Early detection and early diagnosis are the key factors affecting the therapeutic effect of lung cancer treatment. However, accurate and safe early diagnosis methods for lung cancer are still lacking, greatly affecting the survival of lung cancer patients. Lung cancer, as a highly malignant tumor, has attracted the attention of scientists to study its diagnostic biomarkers. These diagnostic biomarkers are diverse, but their value in the early diagnosis of lung cancer remains to be further explored. In this paper, the biomarkers related to the early diagnosis of lung cancer are sorted out, and the latest progress, potential value, advantages, and limitations of these biomarkers in lung cancer diagnosis are reviewed.